(Reuters) -The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts on May 22 to discuss COVID-19 vaccine recommendations for the upcoming immunization campaign.
The meeting comes after the appointment of FDA commissioner Martin Makary, who had raised concerns about a number of public health efforts during the COVID-19 pandemic and opposed vaccine mandates for the general public.
In the U.S., three COVID shots have been authorized for use – Moderna and Pfizer-BioNTech’s/ messenger RNA based vaccines along with Novavax’s protein-based shot.
Investors have been closely monitoring FDA decisions as mass firings at the regulator have sparked concerns about potential erosion of its drug review system.
(Reporting by Christy Santhosh in Bengaluru; Editing by Shinjini Ganguli and Leroy Leo)
Brought to you by www.srnnews.com
